BIOLASE Begins Strategic Partnership to Enter ENT Laser Market

BIOLASE Begins Strategic Partnership to Enter ENT Laser Market 
IRVINE, CA -- (Marketwired) -- 07/25/13 --  BIOLASE, Inc. (NASDAQ:
BIOL), the world's leading manufacturer and distributor of dental
lasers, and a pioneer in laser surgery in other medical specialties,
announced today that it has entered into a strategic agreement with
Valam Corporation ("Valam") to develop, market, and sell office-based
laser systems to otolaryngologists (also known as "Ear, Nose, and
Throat" or "ENT" doctors). The agreement provides BIOLASE(R) with an
ENT laser patent portfolio, plus the know-how and marketing support
of Dr. Yosef Krespi, one of the world's leading authorities on the
use of lasers for the surgical treatment sinusitis, sleep apnea, and
office-based laser procedures. BIOLASE's EPIC(TM) 10 soft-tissue
laser has already been cleared by the U.S. Food and Drug
Administration (the "FDA") for use in ENT surgical procedures. 
Dr. Krespi is Clinical Professor of Otolaryngology at Columbia
University and founding member of the New York Head & Neck Institute,
where he also chairs the Sleep Disorders Center. Valam has been the
vehicle over the years for him to place his innovations in ENT laser
concepts, including lasers for sinusitis, laser microbial killing /
biofilm disruption, and the use of lasers for treating halitosis.
"The Valam team is very excited about this strategic relationship, we
could not think of a better corporate partner than BIOLASE to launch
laser products that are the culmination of years of ENT-specific
surgical laser research and development," said Dr. Krespi of Valam. 
Federico Pignatelli, Chairman and Chief Executive Officer of BIOLASE,
said, "We look forward to being able to offer an elegant,
simple-to-use, precision laser-based biologic cutting tool to the
9,000 practicing otolaryngologists in the United States. BIOLASE has
planned to enter the ENT market with a clinical laser product
offering. Valam and Dr. Krespi give us the opportunity to enter the
ENT space with a robust product and a thought-leader in the field as
our initial spokesperson and product champion." 
"Our partnership with Valam includes an exclusive worldwide license
to all of Valam's ENT-related patents and pending patents, which when
combined with BIOLASE's existing ENT laser-related patents, creates a
formidable patent estate," said Alexander K. Arrow, MD, President and
Chief Operating Officer of BIOLASE. "BIOLASE plans to hire a small
specialized ENT sales force in advance of our ENT launch, which could
occur as soon as the fourth quarter of this year." 
About Valam Corporation
 Valam Corporation was founded in 2005, by
Yosef Krespi, M.D., F.A.C.S. to pursue light and laser based
antimicrobial and biofilm destruction therapies. Valam is
headquartered in New York, NY, with technology development facilities
in Europe and Israel. Valam has built a strong and internationally
recognized board of directors and a team of medical, scientific and
technical experts who are committed to its success. 
About BIOLASE, Inc.
 BIOLASE, Inc. is a biomedical company that
develops, manufactures, and markets innovative lasers in dentistry
and medicine and also markets and distributes high-end 2D and 3D
digital imaging equipment and CAD/CAM intraoral scanners; products
that are focused on technologies that advance the practice of
dentistry and medicine. The Company's proprietary laser products
incorporate over 350 patented and patent-pending technologies
designed to provide biologically clinically superior performance with
less pain and faster recovery times. Its imaginative products provide
cutting-edge technology at competitive prices to deliver the best
results for dentists and patients. BIOLASE's principal products are
revolutionary dental laser systems that perform a broad range of
dental procedures, including cosmetic and complex surgical
applications, and a full line of dental imaging equipment. BIOLASE
has sold more than 22,500 lasers. Other laser products under
development address ophthalmology and other medical and consumer
markets. 
For updates and information on WaterLase and laser dentistry, find
BIOLASE online at www.biolase.com, Facebook at
www.facebook.com/biolaseinc, Twitter at www.twitter.com/biolaseinc,
Pinterest at www.pinterest.com/biolase, LinkedIn at
www.linkedin.com/company/biolase, Instagram at
www.instagram.com/biolaseinc and YouTube at
www.youtube.com/biolasevideos.  
BIOLASE(R), WaterLase(R), and EPIC(TM) are registered trademarks or
trademarks of BIOLASE, Inc. 
For further information, please contact: 
Michael Porter 
Porter, LeVay & Rose, Inc. 
212-564-4700 
 
 
Press spacebar to pause and continue. Press esc to stop.